THEME: "Exploring the Challenges in Pre & Post Formulations and Drug Delivery Systems"
21-22 Mar 2022 
MENA Plaza Hotel Albarsha, Dubai, UAE 
Damascus university, Syria
Title: Antibody-Drug Conjugates Used in Breast Cancers
Aram Abbas is a medical student at Damascus University. He has some
publications in the medical field, and he hopes to participate more in
enriching the medical literature in the future.
The prognosis of breast cancer has radically
changed in recent years and continues to improve due to the broad application
of effective therapies. New targeting strategies including targeted delivery of
cytotoxic drugs via receptor-targeting agents have been developed. I summarize
recent developments of novel antibody-drug conjugates (ADCs) used to control
breast cancer.